We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Arla Ogilvie at Spire include:
Endocrinology and Diabetes Mellitus
Metabolic bone condition
Polycystic ovary syndrome
Dr Arla Ogilvie is a Consultant Physician with a special interest in diabetes and endocrinology. She undertook specialist training in diabetes and endocrinology in the UK and subsequently through the University of Cape Town in South Africa. Dr Ogilvie spent a period of research into lipid metabolism at the University of Cape Town before taking up her first Consultant post in 1995.
Dr Ogilvie returned to the UK in 1998 and joined the team at Watford General Hospital in August 2002. Her areas of special endocrine interest include the management of thyroid disorders, poly-cystic ovarian syndrome and adolescent diabetes. She has a strong interest in medical education and holds an Honorary clinical Lecturer post with UCL/Royal Free Hospitals Medical School.
polycystic ovarian syndrome, diabetes in young people and adolescents.
Fellow of the Royal College of Physicians of Edinburgh
Member of Diabetes UK and the British Endocrine Society
Consultant Endocrinologist, Watford General Hospital.Back to top
The way in which I spend my free time is influenced to a large extent by the social activities and school fixtures of my two children. We all enjoy skiing and also like to get away for family holidays in Scotland and South Africa - hill walking and bird watching (in good weather!). I like to discover good food and wine. Consequently, I look forward to spending more time in my local gym this year!.Back to top
|Telephone||020 8901 5555|
|Private secretary||Jen Rigg|
|Private secretary email@example.com|
11 February 2020
Redbridge-based Spire London East Hospital has been upgraded to a ‘Good’ rating following an inspection by the Care Qual…
04 February 2020
The Paterson Independent Inquiry published its final report on 4 February 2020.